Home Tags Pharmaceuticals
Doctors are calling out a new drug that helps people with addiction for costing more than $1,700 a week — while a generic costs just $1
Two months after it became the first federally approved drug of its kind to treat addiction, doctors are calling out Lucemyra, a new branded medication to treat opioid withdrawal, for costing $1,737 more per week than a similar generic drug.
A pharma CEO says a new depression drug could have lasting effects after one short course, like antibiotics — here’s what experts think
Sage Therapeutics CEO Jeff Jonas said the new drug could help depressed people feel well "with just a two week course of treatment — similar to how antibiotics are used." No existing drug works that way, and this one hasn't yet been studied beyond a limited time frame when most drugs fail.
A drug derived from marijuana has become the first to win federal approval, and experts predict an avalanche effect
GW Pharmaceutical's drug Epidiolex just became the first marijuana-based drug to win FDA approval. Studies suggest its active ingredient, CBD, reduces seizures in two rare types of epilepsy. The approval will likely galvanize future marijuana research.
After 35 years of mediocre depression drugs, pharmaceutical companies are jazzed about several new drugs inspired by the club drug ketamine. Allergan, the multinational drugmaker known for Botox, recently dove into research on an injectable depression drug. Now they're going after an oral pill.
A drug derived from marijuana just got a big lift that will likely make it the first of its kind to get federal approval
A drug derived from marijuana to treat epilepsy is on the brink of winning US government approval. In its third large clinical trial, Epidiolex appeared to significantly reduce the worst symptoms of two severe forms of childhood epilepsy.
The first drug for opioid withdrawal has gotten the green light — and it targets risky symptoms that others ignore
Lofexidine, sold under the brand name Lucemyra, is the first drug of its kind to target the painful symptoms of opioid withdrawal, which can trigger a cycle of use, addiction, and overdose.
Psychedelic drugs appear to fundamentally reorganize the brain — and they’re starting to turn into approved treatments
From magic mushrooms to ketamine, the drugs are being tested for their potential to treat an array of diseases and conditions that currently lack adequate treatments.
A depression drug that researchers have called ‘the most important discovery in half a century’ just got a big lift
Johnson & Johnson plans to file for FDA approval of a nasal formula of ketamine for depression this year. A new study presented on Saturday suggest the drug, called esketamine, is linked with some very positive results, especially in people with the hardest to treat forms of depression.
Shire rejected a $60 billion bid from the Japanese drugmaker Takeda, while Allergan briefly considered getting into the fray on Thursday.
The GW Pharma drug appears to reduce seizures in two types of epilepsy and nears FDA approval. Its active ingredient: the marijuana compound cannabidiol.